|
|
Legal status
Patent expired
| (51) | INT.CL. | C07K 14/04 | (2006.01) |
| C12N 7/04 | (2006.01) | ||
| A61K 39/25 | (2006.01) | ||
| A61K 39/39 | (2006.01) | ||
| A61P 31/22 | (2006.01) |
| (11) | Number of the document | 1858917 |
| (13) | Kind of document | T |
| (96) | European patent application number | 06707446.8 |
| Date of filing the European patent application | 2006-03-01 | |
| (97) | Date of publication of the European application | 2007-11-28 |
| (45) | Date of publication and mention of the grant of the patent | 2014-12-24 |
| (46) | Date of publication of the claims translation | 2015-03-25 |
| (86) | Number | PCT/EP2006/002070 |
| Date | 2006-03-01 |
| (87) | Number | WO 2006/094756 |
| Date | 2006-09-14 |
| (30) | Number | Date | Country code |
| 0504436 | 2005-03-03 | GB |
| (72) |
HANON, Emmanuel J., BE
STEPHENNE, Jean, BE
|
| (73) |
GlaxoSmithKline Biologicals s.a.,
rue de l`Institut 89, 1330 Rixensart,
BE
|
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | Varicella zoster viruso vakcina |
| VARICELLA ZOSTER VIRUS VACCINE |
| Payment date | Validity (years) | Amount | |
| 2025-02-18 | 347.00 EUR |